FGF23 and chronic kidney disease: On the other hand, elevated fibroblast growth factor 23 (FGF23) levels, may account, at least partly, for the dysregulation of monocytic CYP27B1 in uremia and, as such, may contribute to the high cardiovascular and infectious disease and immune system disorder in chronic renal failure (5-10).